middle.news
ARG-007 Shows Breakthrough Neuroprotection in Traumatic Brain Injury Study
10:08am on Tuesday 4th of February, 2025 AEDT
•
Biotechnology
Read Story
ARG-007 Shows Breakthrough Neuroprotection in Traumatic Brain Injury Study
10:08am on Tuesday 4th of February, 2025 AEDT
Key Points
ARG-007 reduces axonal injury and neuroinflammation to levels seen in non-injured animals
Significant improvements observed in motor function and behavioural tests in treated rats
ARG-007 prevents acute increase of neurofilament light protein, a key TBI biomarker
Treatment accelerates weight recovery post-injury, indicating systemic benefits
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Argenica Therapeutics (ASX:AGN)
OPEN ARTICLE